Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oncternal Therapeutics Inc
(NQ:
ONCT
)
1.140
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
116,800
Open
1.140
Bid (Size)
0.8200 (1)
Ask (Size)
0.8500 (1)
Prev. Close
1.140
Today's Range
1.140 - 1.140
52wk Range
1.030 - 13.14
Shares Outstanding
58,711,451
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 15, 2024
Via
Benzinga
Dow Surges Over 100 Points; ModivCare Shares Plummet
September 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Performance
YTD
-89.71%
-89.71%
1 Month
-23.49%
-23.49%
3 Month
-74.09%
-74.09%
6 Month
-87.89%
-87.89%
1 Year
-84.31%
-84.31%
More News
Read More
Crude Oil Surges 3%; Kroger Posts Upbeat Earnings
September 12, 2024
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Mixed; Producer Prices Increase In August
September 12, 2024
Via
Benzinga
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
Recap: Oncternal Therapeutics Q4 Earnings
March 07, 2024
Via
Benzinga
Oncternal Therapeutics's Earnings: A Preview
March 06, 2024
Via
Benzinga
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
Insiders Buying Westlake Chemical Partners And 2 Other Stocks
April 02, 2024
Via
Benzinga
ONCT Stock Earnings: Oncternal Therapeutics Misses EPS, Beats Revenue for Q4 2023
March 07, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
January 29, 2024
Via
Benzinga
American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Monday
January 29, 2024
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Via
Benzinga
Top 5 Health Care Stocks That May Crash This Month
January 22, 2024
Via
Benzinga
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 27, 2023
Via
Benzinga
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
December 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 26, 2023
Via
Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 26, 2023
Via
Benzinga
Crude Oil Rises Over 3%; US Home Prices Increase In October
December 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level
December 26, 2023
Via
Benzinga
Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
December 26, 2023
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 21, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 12, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
December 08, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.